201 related articles for article (PubMed ID: 19351570)
41. PAI-1 donor polymorphism influences long-term kidney graft survival.
Rérolle JP; Munteanu E; Drouet M; Szelag JC; Champtiaux B; Yagoubi F; Preux PM; Aldigier JC; Le Meur Y
Nephrol Dial Transplant; 2008 Oct; 23(10):3325-32. PubMed ID: 18463321
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion.
Schenk JF; Stephan B; Zewinger S; Speer T; Pindur G
Clin Hemorheol Microcirc; 2008; 39(1-4):329-32. PubMed ID: 18503142
[TBL] [Abstract][Full Text] [Related]
43. Plasminogen activator inhibitor-1 plasma concentration in allergic asthma patients during allergen challenge.
Kowal K; Bodzenta-Lukaszyk A; Pampuch A; Szmitkowski M; Donati MB; Iacoviello L
Int Arch Allergy Immunol; 2007; 144(3):240-6. PubMed ID: 17579282
[TBL] [Abstract][Full Text] [Related]
44. A-G-4G haplotype of PAI-1 gene polymorphisms -844 G/A, HindIII G/C, and -675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease.
Adamski MG; Turaj W; Slowik A; Wloch-Kopec D; Wolkow P; Szczudlik A
Acta Neurol Scand; 2009 Aug; 120(2):94-100. PubMed ID: 19154538
[TBL] [Abstract][Full Text] [Related]
45. The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk.
Tsantes AE; Nikolopoulos GK; Bagos PG; Bonovas S; Kopterides P; Vaiopoulos G
Thromb Res; 2008; 122(6):736-42. PubMed ID: 17949795
[TBL] [Abstract][Full Text] [Related]
46. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
[TBL] [Abstract][Full Text] [Related]
47. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
[TBL] [Abstract][Full Text] [Related]
48. The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin systems in determining plasma t-PA and PAI-1 levels.
Asselbergs FW; Williams SM; Hebert PR; Coffey CS; Hillege HL; Navis G; Vaughan DE; van Gilst WH; Moore JH
Thromb Haemost; 2006 Oct; 96(4):471-7. PubMed ID: 17003924
[TBL] [Abstract][Full Text] [Related]
49. Plasminogen activator inhibitor-1 polymorphism (4G/5G) predicts recurrence in nonhyperlipidemic postinfarction patients.
Corsetti JP; Ryan D; Moss AJ; Rainwater DL; Zareba W; Sparks CE
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):548-54. PubMed ID: 18096824
[TBL] [Abstract][Full Text] [Related]
50. Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene.
Iribarren JL; Jimenez JJ; Hernández D; Brouard M; Riverol D; Lorente L; de La Llana R; Nassar I; Perez R; Martinez R; Mora ML
Anesthesiology; 2008 Apr; 108(4):596-602. PubMed ID: 18362590
[TBL] [Abstract][Full Text] [Related]
51. [Association of genetic polymorphism in plasminogen activator inhibitor-1 gene with endometrial hypoplasia in infertile women].
Sun JH; Guan L-; Lin DJ; Dai PF; Pan L; Mu Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Aug; 25(4):462-4. PubMed ID: 18683152
[TBL] [Abstract][Full Text] [Related]
52. uPA and PAI-1 in rectal cancer--relationship to radiotherapy and clinical outcome.
Angenete E; Langenskiöld M; Palmgren I; Falk P; Oresland T; Ivarsson ML
J Surg Res; 2009 May; 153(1):46-53. PubMed ID: 18533186
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.
Speleman L; Kerrebijn JD; Look MP; Meeuwis CA; Foekens JA; Berns EM
Head Neck; 2007 Apr; 29(4):341-50. PubMed ID: 17163465
[TBL] [Abstract][Full Text] [Related]
54. Circadian clock genes cause activation of the human PAI-1 gene promoter with 4G/5G allelic preference.
Chong NW; Codd V; Chan D; Samani NJ
FEBS Lett; 2006 Aug; 580(18):4469-72. PubMed ID: 16857194
[TBL] [Abstract][Full Text] [Related]
55. Urokinase-type plasminogen activator and plasminogen-activator-inhibitor type 1 predict metastases in good prognosis breast cancer patients.
De Cremoux P; Grandin L; Diéras V; Savignoni A; Degeorges A; Salmon R; Bollet MA; Reyal F; Sigal-Zafrani B; Vincent-Salomon A; Sastre-Garau X; Magdelénat H; Mignot L; Fourquet A;
Anticancer Res; 2009 May; 29(5):1475-82. PubMed ID: 19443353
[TBL] [Abstract][Full Text] [Related]
56. Genetic polymorphism in the fibrinolytic system and endometriosis.
Bedaiwy MA; Falcone T; Mascha EJ; Casper RF
Obstet Gynecol; 2006 Jul; 108(1):162-8. PubMed ID: 16816071
[TBL] [Abstract][Full Text] [Related]
57. Impact of plasminogen activator inhibitor-1 gene polymorphisms on primary membranous nephropathy.
Chen CH; Shu KH; Wen MC; Chen KJ; Cheng CH; Lian JD; Wu MJ; Yu TM; Tsai FJ
Nephrol Dial Transplant; 2008 Oct; 23(10):3166-73. PubMed ID: 18495745
[TBL] [Abstract][Full Text] [Related]
58. Epistatic effect of plasminogen activator inhibitor 1 and beta-fibrinogen genes on risk of glomerular microthrombosis in lupus nephritis: interaction with environmental/clinical factors.
Gong R; Liu Z; Li L
Arthritis Rheum; 2007 May; 56(5):1608-17. PubMed ID: 17469143
[TBL] [Abstract][Full Text] [Related]
59. TAFI activity and antigen plasma levels are not increased in acute coronary artery disease patients admitted to a coronary care unit.
Paola Cellai A; Antonucci E; Alessandrello Liotta A; Fedi S; Marcucci R; Falciani M; Giglioli C; Abbate R; Prisco D
Thromb Res; 2006; 118(4):495-500. PubMed ID: 16318869
[TBL] [Abstract][Full Text] [Related]
60. Association of PAI-1 gene polymorphism with survival and chemotherapy-related vascular toxicity in testicular cancer.
de Haas EC; Zwart N; Meijer C; Suurmeijer AJ; Meijer K; Guchelaar HJ; Hoekstra HJ; van Leeuwen FE; Sleijfer DT; Boezen HM; Gietema JA
Cancer; 2010 Dec; 116(24):5628-36. PubMed ID: 20737565
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]